Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|June 18, 2017
EV-3, an endogenous human erythropoietin isoform with distinct functional relevanceChristel Bonnas, Liane Wüstefeld, Daniela Winkler, et al.
Journal of Virological Methods|December 4, 2020
Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasmaChristine von Rhein, Tatjana Scholz, Lisa Henss, et al.
Lab on a Chip|November 15, 2019
Blood platelet enrichment in mass-producible surface acoustic wave (SAW) driven microfluidic chipsCynthia Richard, Armaghan Fakhfouri, Melanie Colditz, et al.
Physiological Reports|September 9, 2023
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male miceStephan R Künzel, Luise Winter, Maximilian Hoffmann, et al.
Stem Cell Reviews and Reports|February 19, 2022
SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron MetabolismRomy Kronstein-Wiedemann, Marlena Stadtmüller, Sofia Traikov, et al.
Frontiers in Immunology|June 23, 2025
Dysregulated monocyte compartment in PACS patientsRomy Kronstein-Wiedemann, Madeleine Teichert, Elisa Michel, et al.
Stem Cell Reviews and Reports|August 26, 2025
Knock Out of miRNA-30a-5p and Reconstitution of the Actin Network Dynamics Partly Restores the Impaired Terminal Erythroid Differentiation during Blood PharmingJessica Thiel, Duran Sürün, Desiree C Brändle, et al.
Scientific Reports|October 31, 2024
Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazineStephan R Künzel, Erik Klapproth, Nick Zimmermann, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2022
Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19Nikolai P Jaschke, Alexander M Funk, Sophie Jonas, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 24, 2025
Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanismIelizaveta Gorodetska, Vasyl Lukiyanchuk, Marta Gawin, et al.
Pageof 3